These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1351044)

  • 61. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas.
    Palanisamy N; Imanishi Y; Rao PH; Tahara H; Chaganti RS; Arnold A
    J Clin Endocrinol Metab; 1998 May; 83(5):1766-70. PubMed ID: 9589690
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutation.
    Ingvarsson S; Geirsdottir EK; Johannesdottir G; Sigbjörnsdóttir BI; Eiriksdottir G; Ragnarsson G; Agnarsson BA; Gudmundsson J; Jonasson JG; Sigurdsson A; Egilsson V; Barkardottir RB
    Cancer Res; 1998 Oct; 58(19):4421-5. PubMed ID: 9766673
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.
    Courjal F; Theillet C
    Cancer Res; 1997 Oct; 57(19):4368-77. PubMed ID: 9331100
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer.
    Chen LC; Neubauer A; Kurisu W; Waldman FM; Ljung BM; Goodson W; Goldman ES; Moore D; Balazs M; Liu E
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3847-51. PubMed ID: 1673792
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
    Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
    Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
    Pan H; Califano J; Ponte JF; Russo AL; Cheng KH; Thiagalingam A; Nemani P; Sidransky D; Thiagalingam S
    Cancer Res; 2005 Mar; 65(5):1664-9. PubMed ID: 15753360
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High frequency of LOH at chromosome 18q in human breast cancer: association with high S-phase fraction and low progesterone receptor content.
    Huiping C; Eiriksdottir G; Sigurdsson A; Sigurgeirsdottir JR; Barkardottir RB; Egilsson V; Ingvarsson S
    Anticancer Res; 1998; 18(2A):1031-6. PubMed ID: 9615760
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genetic alterations in ERBB2-amplified breast carcinomas.
    Isola J; Chu L; DeVries S; Matsumura K; Chew K; Ljung BM; Waldman FM
    Clin Cancer Res; 1999 Dec; 5(12):4140-5. PubMed ID: 10632352
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Breast cancer in young women (< or = 35 years): Genomic aberrations detected by comparative genomic hybridization.
    Weber-Mangal S; Sinn HP; Popp S; Klaes R; Emig R; Bentz M; Mansmann U; Bastert G; Bartram CR; Jauch A
    Int J Cancer; 2003 Nov; 107(4):583-92. PubMed ID: 14520696
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood.
    Raffel C; Gilles FE; Weinberg KI
    Cancer Res; 1990 Feb; 50(3):587-91. PubMed ID: 1967549
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
    Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O
    Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Distinct chromosomal aberrations of ampulla of Vater and pancreatic head cancers detected by laser capture microdissection and comparative genomic hybridization.
    Chang MC; Chang YT; Tien YW; Sun CT; Wu MS; Lin JT
    Oncol Rep; 2005 Oct; 14(4):867-72. PubMed ID: 16142344
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Cytogenetic abnormalities, genetic alterations, and applications for genetic diagnosis in breast cancer].
    Tsukamoto K; Emi M; Nakamura Y
    Nihon Rinsho; 1996 Dec; 54(12):3389-97. PubMed ID: 8976125
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer.
    Huiping C; Sigurgeirsdottir JR; Jonasson JG; Eiriksdottir G; Johannsdottir JT; Egilsson V; Ingvarsson S
    Br J Cancer; 1999 Dec; 81(7):1103-10. PubMed ID: 10584868
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Loss and gain of distinct regions of chromosome 1q in primary breast cancer.
    Bièche I; Champème MH; Lidereau R
    Clin Cancer Res; 1995 Jan; 1(1):123-7. PubMed ID: 9815894
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization.
    Ghazani AA; Arneson N; Warren K; Pintilie M; Bayani J; Squire JA; Done SJ
    Neoplasia; 2007 Jun; 9(6):511-20. PubMed ID: 17603634
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosity.
    Smeds J; Wärnberg F; Norberg T; Nordgren H; Holmberg L; Bergh J
    Acta Oncol; 2005; 44(1):41-9. PubMed ID: 15848905
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer.
    Ito I; Yoshimoto M; Iwase T; Watanabe S; Katagiri T; Harada Y; Kasumi F; Yasuda S; Mitomi T; Emi M
    Br J Cancer; 1995 Mar; 71(3):438-41. PubMed ID: 7880720
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast.
    Beaty MW; Quezado M; Sobel ME; Duray P; Merino MJ
    Int J Surg Pathol; 2005 Jan; 13(1):9-18. PubMed ID: 15735850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.